Dr. Kyaw Moe, MD

Dr. Moe practices at Circle Marina Dialysis in Los Alamitos, California.

Dr. Moe's NPI, 1083649735, was assigned on July 11, 2006. Dr. Moe graduated from University Institute of Medicine 1 in 1996. Dr. Moe holds California license A109324.

Dr. Moe's primary practice is Circle Marina Dialysis, at 3851 Katella Ave, Los Alamitos, CA 90720 in Orange County. The practice phone is (562) 725-3224.

Dr. Moe's primary practice is Circle Marina Dialysis in Los Alamitos, California. Dr. Moe is also affiliated with UCI Health - Orange. The medical group on file is ProHealth Partners. Dmand AI also links Dr. Moe to 3 more hospitals, 5 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moe practices, 11 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Moe's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Moe is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Moe's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Moe treats.

CMS data shows 5,327 Medicare services from Dr. Moe across 12 procedure codes in 2024, for 862 Medicare patients. Medicare paid $592,098 for them.

CMS counts 862 Medicare patients who saw Dr. Moe in 2024. The largest group is 75 to 84, with 305 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 50% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moe's median patient age at 72, with 46% women.

In 2024, Dr. Moe wrote 7,288 Medicare Part D claims for 705 patients. 73% of them were for generic drugs. CMS names the drug for 7,017 of them, across 60 drugs with 11 or more claims each, at $1,925,758 in total drug cost. In 2023, CMS named 6,103 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 50 out of 100 for Dr. Moe for performance year 2024, reported individually. Dr. Moe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moe as offering telehealth.

Dmand AI links 13 papers to Dr. Moe, published from 2011 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Autophagy, Cells, Cultured and Gene Frequency. Dr. Moe's most frequent co-authors are Ramy Magdy Hanna, MD, Yela Jung, MD and Kamyar Zadeh Kalantar-Zadeh, MD.

CMS Open Payments shows 239 general payments to Dr. Moe from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. OPKO Pharmaceuticals, LLC paid the most, $1,080.

Dr. Moe graduated from University Institute of Medicine 1 in 1996.

Dr. Moe is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.